Nykode Therapeutics
Less than 1K followers
NYKD
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Nykode Therapeutics operates in biotechnology. The company is today specialized in the research and development of immunological therapies and vaccines. The solutions are mainly used for the treatment of patients with cancer and other serious health conditions that require long-term treatment. The main business of Nykode Therapeutics is found in the European market.
Read moreMarket cap
-
Turnover
-
Revenue
98.39M
EBIT %
-556.8 %
P/E
-
Dividend yield-%
-
Financial calendar
14.5
2025
Interim report Q1'25
22.5
2025
General meeting '25
20.8
2025
Interim report Q2'25
ShowingAll content types
Nykode Therapeutics - Quarterly report Q4 2024
Nykode Therapeutics - invitation to Q4 2024 financial results presentation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools